Medicare Part B, Breakthrough Drugs Get Reimbursement Boost In Senate COVID-19 Bill

Legislation allows sponsors to request HCPCS code even before US FDA approval, but would extend the sequester until 2030 to pay for the temporary increase in payments for Part B drugs.